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The work reports synthesis of 15 novel 3-((dicyclohexylamino)(substituted 
phenyl/heteryl)methyl)-4-hydroxy-2H-chromen-2-one derivatives 4 (a-o) as potential 
antimicrobial agents in solvent-free condition using Triethyl ammonium sulphate 
[Et3NH][HSO4] as an efficient, eco-friendly and reusable catalyst. Compared to other methods, 
this new method consistently has advantages, including excellent yields, a short reaction time, 
mild reaction conditions and catalyst reusability. The heterocyclic compound Coumarin, is 
associated with diverse biological activities of immense importance. Due to the presence of 
coumarin moiety in various pharmaceutically active compounds, we planned the green synthesis 
of a series of 15 novel compounds containing coumarin moiety coupled with dicyclohexyl rings 
by an eco-friendly ionic-liquid mediated protocol at room temperature by stirring. The structures 
of the synthesized compounds were confirmed by spectral characterization such as IR, 1H NMR, 
13CNMR and Mass spectral studies. All the synthesized compounds 4 (a-o) were evaluated for 
anti-fungal and antibacterial activities and have exhibited promising antimicrobial activity. 





Many drug-resistant human pathogenic microbes have been observed in the past few decades 
[1] and it is serious public health problem in a wide range of infectious disease [2,3]. These 
resistant pathogenic microbes’ strains cause failure in antimicrobial treatment and enhance the 
mortality risks, and sometimes contribute to complications. To overcome this problem the best 
way is the development of new bioactive compounds effective against resistant strains is highly 
needed. In spite of a large number of antibiotics and chemotherapeutics available for medical 
use, antimicrobial resistance created substantial medical need for new classes of antimicrobial 
agents. Design and synthesis of newer antimicrobials will always remain an area of immense 
significance [4-5]. The novel and potent antimicrobial agents can be obtained by modifying the 
structure of a well known antimicrobial agent or the second strategy is to combine together two 
or more different antimicrobial pharmacophores in one molecule.  
Coumarin derivatives are an important class of natural, synthetic compounds and 
pharmacologically active substances displaying a broad range of biological activities including 
cytotoxicity [6], antioxidant [7], antiplasmodial [8], antimalarial [9], antirhinovirus [10], 
antifungal [11] and antibacterial [12].  
The Mannich reaction is one of the most important carbon-carbon bond forming reactions 
in organic synthesis because of its atom economy and potential application in the synthesis of 
biologically active molecules. In this reaction, an mine, two carbonyl compounds, and acid (or 
base) catalysts are used to produce β-amino carbonyl compounds, which constitute various 
pharmaceuticals, natural products and versatile synthetic intermediates [13,14]. Conventional 
catalyst of the classic Mannich reaction involves inorganic and organic acids like HCl [15], 
proline [16], p-dodecybenzenesulfonic acid [17]. Reaction using these catalysts, however, often 
suffers drawbacks including long reaction times, hars  reaction condition, and difficult product 
separation. 
Considering the focus on green synthesis in recent y ars, ionic liquid have attracted attention 
many of researchers. Ionic liquid have been referred as “designer solvents/ green solvents” 
because their physical and chemical properties can be adjusted by varying the cation and anion. 
Mannich reaction have been performed using various nic liquid such as [BMIM][PF6] [18], 
[emim][OTf] [19], [CMMIM][BF 4] [20], [Hmim][PF6] [21] and some other bronsted ionic 
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liquids (22-23). Although extensive work has been done in this area, the disadvantage of the 
above mentioned catalytic systems, are large amount f catalyst required, the necessity of an 
organic co-solvent, cost, the ionic liquids contain halogen, which in some ways, limits their 
“greenness”. Thus synthesizing halogen free, water soluble, economic, reusable and easy to 
prepare ionic liquid was the main aim of our research team. Taking in consideration the above 
mentioned points we have carried out the synthesis of coumarin-dicyclohexyl coupled hybrid 
derivatives 4(a-o) using [Et3NH][HSO4] as an solvent and easily recoverable green catalyst 
(Scheme 1). 
All the synthesized compounds 4(a-o) were screened for in vitro antifungal and 
antibacterial activity.  Minimum inhibitory concentra ion (MIC) values were determined using 
the standard agar method as per CLSI guidelines [24-27]. 
2. RESULTS AND DISCUSSION 
2.1 Chemistry: 
Herein we report the one-pot synthesis of 15 novel 3-((dicyclohexylamino)(substituted 
phenyl/heteryl)methyl)-4-hydroxy-2H-chromen-2-one drivatives 4 (a-o) from three component 
reactions of an suitable aldehydes (1), dicyclohexylamine (2) and 4-hydroxy coumarin (3) in 
presence of [Et3NH][HSO4] as an solvent and catalyst as shown in Scheme 1. 
Scheme 1. One-Pot, three component synthesis of novel 3-((dicyclohexylamino)(substituted 
phenyl/heteryl)methyl)-4-hydroxy-2H-chromen-2-one derivatives 4 (a-o) 
In search of an efficient catalyst and the best experimental reaction conditions, the 
reaction of benzaldehyde (1a), dicyclohexylamine (2) and 4-hydroxy coumarin (3) at room 
temperature was considered as a standard model reaction to obtain 4a.  
Initially, the reaction was carried out in the absence of the catalyst; the product formed in 
a trace/negligible amount Table 1, entry 1. To determine the appropriate concentration of the 
catalyst [Et3NH][HSO4], we investigated the model reaction at different concentrations of 
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[Et3NH][HSO4], such as 5, 10, 15, 20 and 25 mol%. The product 4a formed in 72, 85, 90, 92 and 
92 % yields, respectively. 
Table 1 Effect of [Et3NH][HSO4] catalyst concentration on model reaction 4a 
Entry  [Et3NH][HSO4] mol% Time (min) Yield (%) 
1. No catalyst 90 Trace 
2. 5 85 72 
3. 10 60 85 
4. 15 50 90 
5. 20 30 92 
6. 25 30 92 
 
The increase in concentration of catalyst from 20 to 25 mol% does not increase the yield 
of product. This indicates that 20 mol% of [Et3NH][HSO4] is sufficient for the reaction by 
considering the product yield. 
The re-usability of the ionic liquid [Et3NH][HSO4] was also studied and the results 
obtained are as shown in Table 3. After the completion of the reaction, the reaction mixture was 
quenched with ice crystals and filtered recrystallized using ethanol. The residual ionic liquid was 
washed with diethyl ether, dried under vacuum at 60 0C and reused for subsequent reactions. The 
recovered ionic liquid could be used for five times without obvious loss of catalytic activity. 
Table 3 Reusability of [Et3NH][HSO4] catalyst for model reaction 4a 
Entry  Run Time Yield 
1. 1 30 92 
2. 2 30 92 
3. 3 30 90 
4. 4 30 88 
5. 5 30 88 
 
With these optimized reaction conditions for the model reaction 4a, i.e. 20 mol% 
[Et3NH][HSO4] catalyst, room temperature and solvent-free conditions, we have synthesized 15 
novel 3-((dicyclohexylamino)(substituted phenyl/heteryl)methyl)-4-hydroxy-2H-chromen-2-one 
derivatives 4 (a-o). The physical characterization data of the synthesized compounds 4 (a-o) are 
as  shown in  Table 4 All the synthesized compounds were characterized by 1H-NMR, 13C-NMR, 




Table 4 Physical characterization of synthesized compounds 4 (a-o). 








4a Phenyl 431.25 C28H33NO3 112-114 92 
4b 4-chlorophenyl 465.21 C28H32ClNO3 120-122 95 
4c 2,6-dichlorophenyl 500.17 C28H31Cl2NO3 126-128 90 
4d 4-flurophenyl 449.56 C28H32FNO3 122-124 92 
4e 2,4-diflurophenyl 467.55 C28H31F2NO3 122-124 89 
4f 4-methoxyphenyl 461.59 C29H35NO4 133-135 86 
4g 3,4 dimethoxyphenyl 491.62 C30H37NO5 138-140 84 
4h 3,4,5 trimethoxyphenyl 521.64 C31H39NO6 136-138 82 
4i 4-hydroxyphenyl 447.57 C28H33NO4 128-130 90 
4j 2-hydroxyphenyl 447.57 C28H33NO4 130-132 88 
4k 4-hydroxy-3-methoxyphenyl 477.59 C29H35NO5 144-146 86 
4l 4-hydroxy-3-ethoxyphenyl 491.27 C30H37NO5 140-142 86 
4m Pyridine-2-yl 432.55 C27H32N2O3 148-150 84 
4n Thiophene-2-yl 437.59 C26H31NO3S 140-142 88 
4o Furan-2-yl 421.53 C26H31NO4 148-150 86 
 
2.2 In-vitro antifungal activity 
The newly synthesized compounds 4(a–o) were screened for in vitro antifungal activity 
against different yeast and filamentous fungal pathogens.  All the compounds have shown good 
to moderate antifungal activity as shown in Table 5. The compound 4b, 4c, 4d and 4e having 
electron withdrawing groups exhibited good antifungal activity against these three fungal strains 
Aspergillus fumigates (NCIM 902), Aspergillus flavus (NCIM539) and Aspergillus niger 
(NCIM1196). The compound 4l bearing 4-hydroxy-3-ethoxy was found to be the most active 
compound among the synthesized series having MIC values 25 µg/ml for C. albicans, 28 µg/ml 
for C. glabrata, 28 µg/ml for F. oxysporum, 36 µg/ml for Asp. fumigates, 15 µg/ml for Asp. 









Table 5. In-vitro antifungal activity of synthesized compounds 4 (a-o) 















4a 66 58 55 84 38 43 54 
4b 30 32 34 30 14 15 15 
4c 30 28 35 28 15 18 14 
4d 28 30 30 28 15 20 18 
4e 28 26 30 28 12 15 14 
4f 43 57 39 44 20 22 20 
4g 50 57 35 52 24 20 26 
4h 48 64 45 50 38 34 34 
4i 32 35 35 42 25 28 24 
4j 46 47 38 55 32 30 35 
4k 25 30 28 38 12 15 15 
4l 25 28 28 36 15 12 12 
4m 48 46 40 45 25 22 28 
4n 55 53 58 67 32 38 33 
4o 56 55 55 65 46 49 48 
Miconazole 25 25 25 35 12 12 12 
 aValues are the average of three readings 
2.2 In-vitro antibacterial activity 
 The newly synthesized compounds 4(a–o) were screened for in vitro antibacterial activity 
against different bacterial strains.  All the compounds have shown good to moderate antibacterial 
activity as shown in Table 6 The compound 4b bearing 2,4 difluro was found to be the most 
active compound among the synthesized series having MIC values 48 µg/ml for E. coli, 50 











Table 6: In-vitro Antibacterial activity of the synthesized compounds 4 (a-0). 
Compounds MIC aµg/ml 
 E. coli B. subtilus S. aureus 
5a 70 68 65 
5b 52 50 54 
5c 50 52 52 
5d 50 49 50 
5e 48 50 52 
5f 64 58 55 
5g 62 60 62 
5h 68 68 66 
5i 64 66 67 
5j 68 72 72 
5k 55 55 54 
5l 56 54 54 
5m 68 74 78 
5n 65 74 72 
5o 66 74 70 
Ampicillin 50 50 50 
aValues are the average of three readings 
3. MATERIALS AND METHODS 
3.1. General Information 
All the reactions were performed in oven-dried glass-wares. All reagents and solvents 
were used as obtained from the supplier or recrystallized/redistilled unless otherwise noted. The 
purity of the synthesized compounds was monitored by ascending thin layer chromatography 
(TLC) on silica gel-G (Merck, Darmstadt, Germany) coated aluminum plates, visualized by 
iodine vapor and melting points were determined in open capillary tubes. The FTIR spectra were 
obtained using Jasco FTIR-4000 and peaks were expressed in terms of wave number (cm-1). The 
1H NMR and 13C NMR spectra of synthesized compounds were recorded on Bruker Avance II 
400 NMR Spectrometer at 400 MHz Frequency in CDCl3 and using TMS as internal standard 
(chemical shift δ in ppm), Mass spectra were scanned on Water’s Micromass Q-Tof system 
Elemental analyses (C, H, and N) were done with a FLASHEA 112 Shimadzu’ analyzer 
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(Mumbai, Maharashtra, India) and all analyses were consistent (within 0.4%) with theoretical 
values.  
3.2 Synthesis of 3-((dicyclohexylamino)(substituted phenyl/heteryl)methyl)-4-hydroxy-2H-
chromen-2-one derivatives 4 (a-o) 
A 25 mL a beaker was charged with a mixture of a suitable aldehyde (1.25mmol), 
dicyclohexyamine (1.25mmol), 4-hydroxy coumarin (1.25mmol), and 20 mol % of 
[Et3NH][HSO4] as catalyst and the reaction mixture was stirred at  room temperature. After 
completion of the reaction (monitored by TLC), the mixture was poured into ice cold water. The 
product obtained, was filtered and dried. The corresponding product was obtained in high purity 
after recrystallization of the crude product from ethanol. The authenticity of compounds was 
established by 1H-NMR, 13C-NMR, IR and Mass spectra. 
3-((dicyclohexylamino)(phenyl)methyl)-4-hydroxy-2H-chromen-2-one 4a 
Yield 92%; M. P.: 112-114 0C; IR (KBr vmax in cm
-1): 3160.41(CH stretching of aromatic), 
1708.62 (C-O Stretch), 1646.91 (C=O Stretch); 1HNMR: (CDCl3) δ ppm: 1.11-1.58  (m, 20 H, 
cyclohexyl ring), 2.57 (m, 2H, C-N), 4.60 (s, 1H, CH), 7.22-7.35 (m, 5H, aromatic ring), 7.44-
7.87 (m, 4H, coumarin ring), 15.79 (s, 1H, OH); 13C NMR: (CDCl3) δ ppm: 25.49 (CH2), 25.79 
(CH2), 32.33 (CH2), 33.11 (CH2), 67.89 (CH2-N), 77.89 (CH-N), 93.34 (C), 117.72 (C), 118.00 
(CH), 123.45 (CH), 125.43 (CH), 127.23 (CH), 128.12 (CH), 128.99 (CH), 129.56 (CH), 137.23 
(C), 158.99 (C), 161.89 (C-OH), 162.35 (C=O); m/z: 431.25 (100.0%), 432.25 (30.8%), 433.25 
(5.2%); Molecular formula: C28H33NO3; Elemental Analysis: Calculated (C, H, N, O): 77.93, 
7.71, 3.25, 11.12, Found: 77.95, 7.70, 3.22, 11.15. 
3-((4-chlorophenyl)(dicyclohexylamino)methyl)-4-hydroxy-2H-chromen-2-one 4b 
Yield 95%; M. P.: 120-122 0C; IR (KBr vmax in cm
-1): 3162.41(CH stretching of aromatic), 
1700.62 (C-O Stretch), 1646.77 (C=O Stretch), 740.55 (C-Cl of aromatic ring); 1HNMR: 
(CDCl3) δ ppm: 1.11-1.58  (m, 20 H, cyclohexyl ring), 2.55 (m, 2H, C-N), 4.65 (s, 1H, CH), 
7.32-7.39 (m, 4H, aromatic ring), 7.43-7.87  (m, 4H, coumarin ring), 15.74 (s, 1H, OH); 13C 
NMR: (CDCl3) δ ppm: 25.55 (CH2), 25.79 (CH2), 32.33 (CH2), 33.15 (CH2), 67.80 (CH2-N), 
77.88 (CH-N), 93.44 (C), 116.72 (C), 117.99 (CH), 123.34 (CH), 125.56 (CH), 128.00 (CH), 
128.39 (CH), 128.55 (CH), 129.34 (CH), 132.87 (C-Cl), 135.3 (C), 158.89 (C), 161.79 (C-OH), 
162.55 (C=O); m/z: 465.21 (100.0%), 467.20 (32.0%), 466.21 (30.8%), 468.21 (10.0%), 467.21 
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(5.2%), 469.21 (1.7%); Molecular formula: C28H32ClNO3; Elemental Analysis: Calculated (C, H, 
Cl, N, O): 72.17, 6.92, 7.61, 3.01, 10.30, Found: 72.15, 6.90, 7.65, 3.00, 10.33. 
3-((2,6-dichlorophenyl)(dicyclohexylamino)methyl)-4-hydroxy-2H-chromen-2-one 4c 
Yield 90%; M. P.: 126-128 0C; IR (KBr vmax in cm
-1): 3162.33(CH stretching of aromatic), 
1707.12 (C-O Stretch), 1645.77 (C=O Stretch), 744.55 (C-Cl of aromatic ring); 1HNMR: 
(CDCl3) δ ppm: 1.12-1.59  (m, 20 H, cyclohexyl ring), 2.59 (m, 2H, C-N), 4.67 (s, 1H, CH), 
7.40-7.50 (m, 3H, aromatic ring ), 7.49-7.88 (m, 4H, coumarin ring), 15.74 (s, 1H, OH); 13C 
NMR: (CDCl3) δ ppm: 25.55 (CH2), 25.79 (CH2), 32.33 (CH2), 33.15 (CH2), 67.80 (CH2-N), 
77.88 (CH-N), 93.44 (C), 116.72 (C), 117.99 (CH), 123.38 (CH), 125.66 (CH), 126.78 (CH), 
128.56 (CH), 129.00 (CH), 135.55 (C-Cl), 158.99 (C), 161.59 (C-OH), 162.55 (C=O); m/z: 
499.17 (100.0%), 501.17 (69.1%), 500.17 (31.1%), 502.17 (19.7%), 503.16 (10.2%), 503.17 
(3.4%), 504.17 (3.3%); Molecular formula: C28H31Cl2NO3; Elemental Analysis: Calculated (C, 
H, Cl, N, O): 67.20, 6.24, 14.17, 2.80, 9.59, Found: 67.18, 6.22, 14.19, 2.78, 9.56. 
3-((dicyclohexylamino)(4-fluorophenyl)methyl)-4-hydroxy-2H-chromen-2-one 4d 
Yield 92%; M. P.: 122-124 0C; IR (KBr vmax in cm
-1): 3160.33(CH stretching of aromatic), 
1708.32 (C-O Stretch), 1648.67 (C=O Stretch), 1053.44 (C-F of aromatic rings); 1HNMR: 
(CDCl3) δ ppm: 1.13-1.60  (m, 20 H, cyclohexyl ring), 2.59 (m, 2H, C-N), 4.60 (s, 1H, CH), 
7.13-7.25 (m, 4H, aromatic ring ), 7.49-7.88 (m, 4H, coumarin ring), 15.74 (s, 1H, OH); 13C 
NMR: (CDCl3) δ ppm: 25.55 (CH2), 25.79 (CH2), 32.33 (CH2), 33.15 (CH2), 67.80 (CH2-N), 
77.88 (CH-N), 93.44 (C), 115.55 (C), 116.72 (C), 117.99 (CH), 123.35 (CH), 125.66 (CH), 
128.06 (CH), 129.99 (CH), 132.55 (C), 158.99 (C), 160.00 (C-F), 161.59 (C-OH), 162.55 
(C=O); m/z: 449.24 (100.0%), 450.24 (30.8%), 451.24 (5.2%); Molecular formula: C28H32FNO3; 
Elemental Analysis: Calculated (C, H, F, N, O): 74.81, 7.17, 4.23, 3.12, 10.68, Found: 74.80, 
7.14, 4.25, 3.10, 10.67. 
3-((dicyclohexylamino)(2,4-difluorophenyl)methyl)-4-hydroxy-2H-chromen-2-one 4e 
Yield 89%; M. P.: 122-124 0C; IR (KBr vmax in cm
-1): 3166.33(CH stretching of aromatic), 
1708.32 (C-O Stretch), 1648.67 (C=O Stretch), 1055.64 (C-F of aromatic rings); 1HNMR: 
(CDCl3) δ ppm: 1.12-1.60  (m, 20 H, cyclohexyl ring), 2.60 (m, 2H, C-N), 4.60 (s, 1H, CH), 
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6.63-7.15 (m, 3H, aromatic ring ), 7.45-7.86 (m, 4H, coumarin ring), 15.75 (s, 1H, OH); 13C 
NMR: (CDCl3) δ ppm: 25.45 (CH2), 26.49 (CH2), 31.33 (CH2), 33.15 (CH2), 66.40 (CH2-N), 
70.86 (CH-N), 93.44 (C), 105.56 (CH), 111.11 (CH), 115.55 (C), 116.82 (C), 117.90 (CH), 
124.15 (CH), 125.96 (CH), 128.00 (CH), 132.00 (CH), 158.19 (C), 159.90 (C-F), 161.07 (C-F), 
161.59 (C-OH), 162.55 (C=O); m/z: 467.23 (100.0%), 468.23 (30.8%), 469.23 (5.2%); 
Molecular formula: C28H31F2NO3; Elemental Analysis: Calculated (C, H, F, N, O):  71.93, 6.68, 
8.13, 3.00, 10.27, Found: 71.90, 6.64, 8.15, 3.27, 10.28. 
3-((dicyclohexylamino)(4-methoxyphenyl)methyl)-4-hydroxy-2H-chromen-2-one 4f 
Yield 86%; M. P.: 133-135 0C; IR (KBr vmax in cm
-1): 3162.33(CH stretching of aromatic), 
1707.32 (C-O Stretch), 1650.67 (C=O Stretch), 1230. (C-OCH3 of aromatic rings); 
1HNMR: 
(CDCl3) δ ppm: 1.12-1.58  (m, 20 H, cyclohexyl ring), 2.62 (m, 2H, C-N), 3.53 (s, 3H, OCH3), 
4.57 (s, 1H, CH), 6.68-7.17 (m, 4H, aromatic ring ), 7.42-7.86 (m, 4H, coumarin ring), 15.75 (s, 
1H, OH); 13C NMR: (CDCl3) δ ppm: 25.45 (CH2), 26.49 (CH2), 31.33 (CH2), 33.15 (CH2), 56.65 
(OCH3), 66.40 (CH2-N), 70.86 (CH-N), 93.44 (C), 114.77 (CH), 116.72 (C), 117.59 (CH), 
123.95 (CH), 125.96 (CH), 127.56 (CH), 128.00 (CH), 129.77 (C), 158.19 (C), 159.99 (C-
OCH3), 161.59 (C-OH), 162.55 (C=O); m/z: 461.26 (100.0%), 462.26 (31.9%), 463.26 (5.7%); 
Molecular formula: C29H35NO4; Elemental Analysis: Calculated (C, H, N, O):  75.46, 7.64, 3.03, 
13.86, Found: 75.44, 7.61, 3.00, 13.88. 
3-((dicyclohexylamino)(3,4-dimethoxyphenyl)methyl)-4-hydroxy-2H-chromen-2-one 4g 
Yield 84%; M. P.: 138-140 0C; IR (KBr vmax in cm
-1): 3160.53(CH stretching of aromatic), 
1709.52 (C-O Stretch), 1655.17 (C=O Stretch), 1235.0  (C-OCH3 of aromatic rings); 
1HNMR: 
(CDCl3) δ ppm: 1.13-1.59  (m, 20 H, cyclohexyl ring), 2.58 (m, 2H, C-N), 3.55 (s, 6H, OCH3), 
4.57 (s, 1H, CH), 6.68-7.00 (m, 3H, aromatic ring ), 7.45-7.86 (m, 4H, coumarin ring), 15.79 (s, 
1H, OH); 13C NMR: (CDCl3) δ ppm: 25.55 (CH2), 24.99 (CH2), 33.23 (CH2), 34.15 (CH2), 69.40 
(CH2-N), 77.86 (CH-N), 56.66 (OCH3), 94.34 (C), 112.99 (CH), 113.79 (CH), 117.02 (C), 
117.89 (CH), 120.09 (CH), 123.95 (CH), 125.96 (CH), 128.00 (CH), 130.57 (C), 148.45 (C-
OCH3), 149.39 (C-OCH3), 158.10 (C), 162.19 (C-OH), 162.55 (C=O); m/z: 491.27 (100.0%), 
492.27 (33.1%), 493.27 (6.3%); Molecular formula: C30H37NO5; Elemental Analysis: Calculated 




Yield 82%; M. P.: 136-138 0C; IR (KBr vmax in cm
-1): 3168.03(CH stretching of aromatic), 
1710.02 (C-O Stretch), 1658.07 (C=O Stretch), 1234.9  (C-OCH3 of aromatic rings); 
1HNMR: 
(CDCl3) δ ppm: 1.14-1.60  (m, 20 H, cyclohexyl ring), 2.59 (m, 2H, C-N), 3.56 (s, 9H, OCH3), 
4.59 (s, 1H, CH), 6.29-6.90 (m, 2H, aromatic ring ), 7.42-7.89 (m, 4H, coumarin ring), 15.79 (s, 
1H, OH); 13C NMR: (CDCl3) δ ppm: 25.39 (CH2), 25.66 (CH2), 32.73 (CH2), 34.15 (CH2), 56.65 
(OCH3), 62.56 (OCH3), 70.40 (CH2-N), 78.46 (CH-N), 93.44 (C), 106.22 (CH), 116.92 (C), 
117.59 (CH), 124.15 (CH), 126.06 (CH), 128.10 (CH), 131.77 (C), 137.78 (C-OCH3), 155.66 (C-
OCH3), 158.11 (C), 162.09 (C-OH), 162.75 (C=O); m/z: 521.28 (100.0%), 522.28 (34.2%), 
523.28 (6.8%), 524.29 (1.0%); Molecular formula: C31H39NO6; Elemental Analysis: Calculated 
(C, H, N, O):  71.38, 7.54, 2.69, 18.40, Found: 71.35, 7.52, 2.65, 18.42. 
3-((dicyclohexylamino)(4-hydroxyphenyl)methyl)-4-hydroxy-2H-chromen-2-one 4i 
Yield 90%; M. P.: 128-130 0C; IR (KBr vmax in cm
-1): 3333.56 (C-OH of aromatic ring), 
3170.03(CH stretching of aromatic), 1715.02 (C-O Stretch), 1660.07 (C=O Stretch); 1HNMR: 
(CDCl3) δ ppm: 1.14-1.60  (m, 20 H, cyclohexyl ring), 2.59 (m, 2H, C-N), 4.59 (s, 1H, CH), 
6.29-6.90 (m, 4H, aromatic ring ), 7.42-7.89 (m, 4H, coumarin ring), 15.79 (s, 1H, OH); 13C 
NMR: (CDCl3) δ ppm: 25.39 (CH2), 25.66 (CH2), 32.73 (CH2), 34.15 (CH2), 66.54 (C), 78.46 
(CH-N), 92.64 (C), 116.22 (CH), 116.92 (C), 117.59 (CH), 123.95 (CH), 124.86 (CH), 128.10 
(CH), 129.17 (C), 131.77 (C), 158.11 (C), 159.00 (C-OH), 161.09 (C-OH), 162.95 (C=O); m/z: 
447.24 (100.0%), 448.24 (30.7%), 449.25 (5.4%); Molecu ar formula: C28H33NO4; Elemental 
Analysis: Calculated (C, H, N, O):  75.14, 7.43, 3.13, 14.30, Found: 75.12, 7.41, 3.10, 14.32. 
3-((dicyclohexylamino)(2-hydroxyphenyl)methyl)-4-hydroxy-2H-chromen-2-one 4j 
Yield 88%; M. P.: 130-132 0C; IR (KBr vmax in cm
-1): 3333.86 (C-OH of aromatic ring), 
3172.03(CH stretching of aromatic), 1720.02 (C-O Stretch), 1665.00 (C=O Stretch); 1HNMR: 
(CDCl3) δ ppm: 1.14-1.62  (m, 20 H, cyclohexyl ring), 2.55 (m, 2H, C-N), 4.59 (s, 1H, CH), 
6.29-6.90 (m, 4H, aromatic ring ), 7.43-7.88 (m, 4H, coumarin ring), 15.79 (s, 1H, OH); 13C 
NMR: (CDCl3) δ ppm: 25.33 (CH2), 25.65 (CH2), 32.72 (CH2), 34.25 (CH2), 66.64 (C), 79.36 
(CH-N), 93.54 (C), 116.21 (CH), 116.91 (C), 117.48 (CH), 122.95 (CH), 124.86 (CH), 128.19 
(CH), 129.07 (C), 131.87 (C), 158.91 (C), 159.20 (C-OH), 161.19 (C-OH), 162.96 (C=O); m/z: 
14 
 
447.24 (100.0%), 448.24 (30.7%), 449.25 (5.4%); Molecu ar formula: C28H33NO4; Elemental 
Analysis: Calculated (C, H, N, O):  75.14, 7.43, 3.13, 14.30, Found: 75.13, 7.40, 3.11, 14.31. 
3-((dicyclohexylamino)(4-hydroxy-3-methoxyphenyl)methyl)-4-hydroxy-2H-chromen-2-one 4k 
Yield 86%; M. P.: 144-146 0C; IR (KBr vmax in cm
-1): 3334.56 (C-OH of aromatic ring), 
3170.03(CH stretching of aromatic), 1725.02 (C-O Stretch), 1665.10 (C=O Stretch), 1234.95 (C-
OCH3 of aromatic rings); 
1HNMR: (CDCl3) δ ppm: 1.14-1.62  (m, 20 H, cyclohexyl ring), 2.55 
(m, 2H, C-N), 3.57 (s, 3H, OCH3), 4.59 (s, 1H, CH), 6.29-6.97 (m, 3H, aromatic ring ), 7.43-7.88 
(m, 4H, coumarin ring), 15.79 (s, 1H, OH); 13C NMR: (CDCl3) δ ppm: 25.33 (CH2), 25.65 
(CH2), 32.72 (CH2), 34.25 (CH2), 56.65 (OCH3), 66.64 (C), 79.36 (CH-N), 93.54 (C), 114.48 
(CH), 115.78 (CH), 116.61 (CH), 116.91 (C), 120.95 (CH), 123.86 (CH), 125.19 (CH), 129.07 
(C), 131.87 (C), 147.77 (C-OCH3), 148.99 (C-OH), 155.91 (C), 161.19 (C-OH), 162.96 (C=O); 
m/z: 477.25 (100.0%), 478.25 (31.7%), 479.26 (6.0%); Molecular formula: C29H35NO5; 
Elemental Analysis: Calculated (C, H, N, O):  72.93, 7.39, 2.93, 16.75, Found: 72.91, 7.36, 2.90, 
16.77. 
3-((dicyclohexylamino)(3-ethoxy-4-hydroxyphenyl)methyl)-4-hydroxy-2H-chromen-2-one 4l
Yield 86%; M. P.: 140-142 0C; IR (KBr vmax in cm
-1): 3333.66 (C-OH of aromatic ring), 
3170.03(CH stretching of aromatic), 1725.02 (C-O Stretch), 1665.10 (C=O Stretch); 1HNMR: 
(CDCl3) δ ppm: 1.14-1.62  (m, 20 H, cyclohexyl ring), 1.65 (t, 3H, OCH2OCH3 ), 2.55 (m, 2H, 
C-N), 3.57 (s, 3H, OCH3), 4.09 (q, 2H, OCH2OCH3), 4.59 (s, 1H, CH), 5.35 (s, 1H, OH), 6.69-
6.87 (m, 3H, aromatic ring ), 7.43-7.88 (m, 4H, coumarin ring), 16.79 (s, 1H, OH); 13C NMR: 
(CDCl3) δ ppm: 14.88 (CH3), 25.30 (CH2), 25.65 (CH2), 32.72 (CH2), 34.25 (CH2), 65.10 
(OCH2), 66.65 (C), 77.86 (CH-N), 92.54 (C), 114.58 (CH), 114.78 (CH), 116.51 (CH), 116.91 
(C), 119.95 (CH), 123.76 (CH), 125.39 (CH), 128.07 (CH), 130.47 (C), 147.87 (C-OH), 148.99 
(C-OCH2CH3), 153.91 (C), 162.19 (C-OH), 163.06 (C=O); m/z: 491.27 (100.0%), 492.27 
(33.1%), 493.27 (6.3%); Molecular formula: C30H37NO5; Elemental Analysis: Calculated (C, H, 






Yield 84%; M. P.: 148-150 0C; IR (KBr vmax in cm
-1): 3170.03(CH stretching of aromatic), 
1725.02 (C-O Stretch), 1665.10 (C=O Stretch); 1HNMR: (CDCl3) δ ppm: 1.14-1.62  (m, 20 H, 
cyclohexyl ring), 2.55 (m, 2H, C-N), 4.59 (s, 1H, CH), 7.31-7.46 (m, 2H, pyridine ring ), 7.43-
7.80 (m, 4H, coumarin ring), 7.73 (d, 2H, CH2), 8.46 (d, 2H, CH2), 16.79 (s, 1H, OH); 
13C NMR: 
(CDCl3) δ ppm: 25.30 (CH2), 25.65 (CH2), 32.72 (CH2), 34.25 (CH2), 54.33 (CH-N), 66.22 (C), 
92.65 (C), 116.89 (C), 117. 45 (CH), 121.21 (CH), 123.34 (CH), 126.87 (CH), 128.78 (CH), 
136.77 (CH), 148.67 (CH), 152.33 (C), 155.22 (C), 161. 8 (C=O), 163.17 (C-OH); m/z: 432.24 
(100.0%), 433.24 (29.9%), 434.25 (4.9%); Molecular formula: C27H32N2O3; Elemental Analysis: 
Calculated (C, H, N, O): 74.97, 7.46, 6.48, 11.10, Found: 74.95, 7.44, 6.44, 11.11.  
3-((dicyclohexylamino)(thiophen-2-yl)methyl)-4-hydroxy-2H-chromen-2-one  4n 
Yield 88%; M. P.: 140-142 0C; IR (KBr vmax in cm
-1): 3170.03(CH stretching of aromatic), 
1725.02 (C-O Stretch), 1665.10 (C=O Stretch); 1HNMR: (CDCl3) δ ppm: 1.14-1.62  (m, 20 H, 
cyclohexyl ring), 2.57 (m, 2H, C-N), 4.49 (s, 1H, CH), 6.77-7.40 (m, 3H, thiophene ring ), 7.43-
7.80 (m, 4H, coumarin ring), 16.79 (s, 1H, OH); 13C NMR: (CDCl3) δ ppm: 25.30 (CH2), 25.65 
(CH2), 32.72 (CH2), 34.25 (CH2), 54.77 (CH-N), 66.29 (C), 92.55 (C), 116.69 (C), 117. 15 (CH), 
123.21 (CH), 125.56 (CH), 125.99 (CH), 126.75 (CH), 127.78 (CH), 128.76 (CH), 139.89 (C), 
153.45 (C), 162.21 (C-OH), 163.00 (C=O); 437.20 (100.0%), 438.21 (28.6%), 439.21 (4.8%), 
439.20 (4.6%), 440.20 (1.3%), 438.20 (1.2%); Molecuar formula: C26H31NO3S; Elemental 
Analysis: Calculated (C, H, N, O, S): 71.36, 7.14, 3.20, 10.97, 7.33; Found: 71.34, 7.12, 3.18, 
10.98, 7.32. 
3-((dicyclohexylamino)(furan-2-yl)methyl)-4-hydroxy-2H-chromen-2-one 4o 
Yield 86%; M. P.: 148-150 0C; IR (KBr vmax in cm
-1): 3170.03(CH stretching of aromatic), 
1725.02 (C-O Stretch), 1665.10 (C=O Stretch); 1HNMR: (CDCl3) δ ppm: 1.17-1.72  (m, 20 H, 
cyclohexyl ring), 2.58 (m, 2H, C-N), 4.89 (s, 1H, CH), 6.27-6.50 (m, 2H, thiophene ring ), 7.40-
7.89 (m, 4H, coumarin ring), 16.79 (s, 1H, OH); 13C NMR: (CDCl3) δ ppm: 25.38 (CH2), 25.75 
(CH2), 32.79 (CH2), 34.85 (CH2), 55.37 (CH-N), 63.89 (C), 93.35 (C), 106.77 (CH), 110.78 
(CH), 116.79 (CH), 116.99 (C), 123.55 (CH), 125.78 (CH), 128.87 (CH), 143.44 (CH), 152.36 
(C), 154.00 (C), 161.99 (C-OH), 162.67 (C=O); m/z: 421.23 (100.0%), 422.23 (28.6%), 423.23 
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(4.9%); Molecular formula: C26H31NO4; Elemental Analysis: Calculated (C, H, N, O):  74.08, 
7.41, 3.32, 15.18, Found: 74.08, 7.41, 3.32, 15.18. 
3.3 In-vitro antimicrobial activity 
All the synthesized compounds were screened for in vitro antifungal and antibacterial 
activity.  The antibacterial activity was evaluated against three human pathogenic bacterial 
strains, such as Escherichia coli (NCIM-2256), Bacillus subtilis (NCIM-2063) and 
Staphylococcus aureus (NCIM-2901). The antifungal activity was evaluated against seven 
human pathogenic fungal strains, such as C ndida albicans (NCIM3471), Candida glabrata 
(NCYC 388), Fusarium oxysporum (NCIM1332), Aspergillus fumigates (NCIM 902), 
Aspergillus flavus (NCIM539), Aspergillus niger (NCIM1196), Cryptococcus neoformans 
(NCIM576), which are often encountered clinically, and were compared with standard drug, 
miconazole (Table 4). Minimum inhibitory concentration (MIC) values were determined using 
the standard agar method as per CLSI guidelines [24-27]. 
4. CONCLUSION 
In conclusion, a novel series of 3-((dicyclohexylamino)(substituted 
phenyl/heteryl)methyl)-4-hydroxy-2H-chromen-2-one drivatives 4 (a-o) have been synthesized 
using Green protocol. The synthesized compounds were evaluated for their antifungal activity. 
Use of green catalyst, i.e. triethyl ammonium sulphate as an ionic liquid helped us in the 
synthesis of expected derivatives in good yields and is advantageous being an eco-friendly 
method. The mild reaction conditions, excellent yields in shorter reaction time and evasion of 
cumbersome work-up procedures make this process economically lucrative for industrial 
application with the advantage of reusability of catalyst. In the present series the compound 4e 
with 2,4-di Fluro substituent  on phenyl group found to be most potent antibacterial agent. The 
compound 4k with 4-hydroxy-3-methoxy on phenyl group found to be most potent antibacterial 
agent. 
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